CHAMBERLAIN UNIVERSITY – NR 565 ADVANCED
PHARMACOLOGY FUNDAMENTALS MIDTERM –
ORIGINAL PRACTICE QUESTIONS AND ANSWERS
| 2026/2027 LATEST UPDATE
SECTION 1: FOUNDATIONS OF PHARMACOLOGY
Questions 1–25
1. Which pharmacokinetic process describes movement of a drug from the administration
site into systemic circulation?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Correct Answer: Absorption
Rationale: Absorption is the movement of a drug from its administration site into systemic
circulation. Distribution occurs after the drug enters circulation and involves movement into
tissues. Metabolism chemically alters drugs, primarily in the liver, while excretion removes
drugs and metabolites, commonly through the kidneys.
2. What characteristic most directly determines the fraction of an orally administered
medication that reaches systemic circulation unchanged?
A) Volume of distribution
B) Bioavailability
C) Clearance
D) Half-life
Correct Answer: Bioavailability
Rationale: Bioavailability represents the fraction of an administered dose that reaches
systemic circulation in active form. Oral drugs may have reduced bioavailability because of
incomplete absorption or first-pass metabolism. Volume of distribution describes tissue
distribution, clearance describes elimination, and half-life describes the time required for
plasma concentration to decrease by half.
,3. A medication with a very large volume of distribution is most likely to:
A) Remain almost entirely within plasma
B) Be eliminated immediately by the kidneys
C) Distribute extensively into tissues
D) Have complete oral absorption
Correct Answer: Distribute extensively into tissues
Rationale: A large volume of distribution suggests that substantial amounts of drug leave the
vascular compartment and distribute into tissues. Highly protein-bound or lipid-soluble
medications can demonstrate this characteristic. Volume of distribution does not directly
establish oral absorption or renal elimination, which are separate pharmacokinetic
processes.
4. Which statement best explains hepatic first-pass metabolism?
A) A drug is excreted unchanged in urine before absorption
B) A medication is distributed into adipose tissue before entering blood
C) A drug bypasses the liver after oral administration
D) A portion of an orally administered drug is metabolized before reaching systemic
circulation
Correct Answer: A portion of an orally administered drug is metabolized before reaching
systemic circulation
Rationale: First-pass metabolism occurs when orally administered medication passes through
the intestinal wall and liver before entering systemic circulation. Significant first-pass
metabolism can substantially reduce bioavailability. This phenomenon helps explain why
some medications require higher oral doses or alternative administration routes.
5. Which pharmacodynamic concept describes the relationship between drug
concentration and the resulting biological effect?
A) Dose-response relationship
B) Renal clearance
C) Bioavailability
D) Absorption constant
Correct Answer: Dose-response relationship
Rationale: A dose-response relationship describes how changes in drug exposure influence
the magnitude of a pharmacologic effect. It helps clinicians understand potency, efficacy,
,therapeutic effects, and toxicity. Bioavailability, absorption, and renal clearance instead
describe pharmacokinetic processes governing what happens to a drug within the body.
6. Why is the therapeutic index clinically useful?
A) It identifies the drug’s route of administration
B) It compares toxic and effective doses
C) It determines renal blood flow
D) It measures oral absorption
Correct Answer: It compares toxic and effective doses
Rationale: The therapeutic index provides an indication of a medication’s safety margin by
comparing doses associated with toxicity and desired effects. A narrow therapeutic index
means relatively small changes in concentration can produce toxicity or treatment failure.
Such medications generally require particularly careful dosing and monitoring.
7. Which physiologic change commonly affects medication handling in older adults?
A) Increased renal clearance
B) Increased total body water
C) Reduced renal function
D) Increased hepatic blood flow
Correct Answer: Reduced renal function
Rationale: Aging is commonly associated with reduced renal function, which can decrease
clearance of renally eliminated medications. Older adults may also experience changes in
hepatic metabolism, body composition, and protein binding. These alterations can increase
drug exposure and adverse effects, making individualized dosing and monitoring especially
important.
8. A medication requiring CYP450 metabolism would be most affected by which situation?
A) Increased dietary fiber alone
B) A clinically significant enzyme inhibitor
C) Increased skeletal muscle mass
D) A medication with identical pharmacologic effects
Correct Answer: A clinically significant enzyme inhibitor
Rationale: CYP450 inhibitors can decrease metabolism of susceptible medications, potentially
increasing their plasma concentrations and toxicity. Conversely, CYP450 inducers may
, accelerate metabolism and reduce drug exposure. The clinical effect depends on the specific
enzyme, substrate, inhibitor or inducer, and therapeutic window of the medication involved.
9. Which finding most strongly suggests a pharmacodynamic drug interaction?
A) One drug changes another drug’s renal clearance
B) One drug alters gastrointestinal absorption
C) Two drugs produce additive physiologic effects
D) One drug increases hepatic metabolism of another
Correct Answer: Two drugs produce additive physiologic effects
Rationale: Pharmacodynamic interactions occur when drugs influence the same physiologic
pathway or response without necessarily changing drug concentrations. Additive sedation
from two central nervous system depressants is an example. Pharmacokinetic interactions
instead alter absorption, distribution, metabolism, or excretion and therefore change drug
exposure.
10. When evaluating medication safety during pregnancy, which period generally
represents the greatest concern for major structural fetal abnormalities?
A) First trimester
B) Second trimester
C) Third trimester
D) Postpartum period
Correct Answer: First trimester
Rationale: Organogenesis occurs primarily during the first trimester, making the developing
embryo particularly vulnerable to teratogenic effects. Drug exposure during later pregnancy
can still cause clinically important fetal or neonatal effects, including altered growth or
toxicity. Therefore, medication decisions require risk-benefit assessment throughout
pregnancy.
11. Which resource specifically provides guidance regarding potentially inappropriate
medications in many older adults?
A) Glasgow Coma Scale
B) Beers Criteria
C) Apgar Score
D) Wells Criteria
Correct Answer: Beers Criteria
PHARMACOLOGY FUNDAMENTALS MIDTERM –
ORIGINAL PRACTICE QUESTIONS AND ANSWERS
| 2026/2027 LATEST UPDATE
SECTION 1: FOUNDATIONS OF PHARMACOLOGY
Questions 1–25
1. Which pharmacokinetic process describes movement of a drug from the administration
site into systemic circulation?
A) Absorption
B) Distribution
C) Metabolism
D) Excretion
Correct Answer: Absorption
Rationale: Absorption is the movement of a drug from its administration site into systemic
circulation. Distribution occurs after the drug enters circulation and involves movement into
tissues. Metabolism chemically alters drugs, primarily in the liver, while excretion removes
drugs and metabolites, commonly through the kidneys.
2. What characteristic most directly determines the fraction of an orally administered
medication that reaches systemic circulation unchanged?
A) Volume of distribution
B) Bioavailability
C) Clearance
D) Half-life
Correct Answer: Bioavailability
Rationale: Bioavailability represents the fraction of an administered dose that reaches
systemic circulation in active form. Oral drugs may have reduced bioavailability because of
incomplete absorption or first-pass metabolism. Volume of distribution describes tissue
distribution, clearance describes elimination, and half-life describes the time required for
plasma concentration to decrease by half.
,3. A medication with a very large volume of distribution is most likely to:
A) Remain almost entirely within plasma
B) Be eliminated immediately by the kidneys
C) Distribute extensively into tissues
D) Have complete oral absorption
Correct Answer: Distribute extensively into tissues
Rationale: A large volume of distribution suggests that substantial amounts of drug leave the
vascular compartment and distribute into tissues. Highly protein-bound or lipid-soluble
medications can demonstrate this characteristic. Volume of distribution does not directly
establish oral absorption or renal elimination, which are separate pharmacokinetic
processes.
4. Which statement best explains hepatic first-pass metabolism?
A) A drug is excreted unchanged in urine before absorption
B) A medication is distributed into adipose tissue before entering blood
C) A drug bypasses the liver after oral administration
D) A portion of an orally administered drug is metabolized before reaching systemic
circulation
Correct Answer: A portion of an orally administered drug is metabolized before reaching
systemic circulation
Rationale: First-pass metabolism occurs when orally administered medication passes through
the intestinal wall and liver before entering systemic circulation. Significant first-pass
metabolism can substantially reduce bioavailability. This phenomenon helps explain why
some medications require higher oral doses or alternative administration routes.
5. Which pharmacodynamic concept describes the relationship between drug
concentration and the resulting biological effect?
A) Dose-response relationship
B) Renal clearance
C) Bioavailability
D) Absorption constant
Correct Answer: Dose-response relationship
Rationale: A dose-response relationship describes how changes in drug exposure influence
the magnitude of a pharmacologic effect. It helps clinicians understand potency, efficacy,
,therapeutic effects, and toxicity. Bioavailability, absorption, and renal clearance instead
describe pharmacokinetic processes governing what happens to a drug within the body.
6. Why is the therapeutic index clinically useful?
A) It identifies the drug’s route of administration
B) It compares toxic and effective doses
C) It determines renal blood flow
D) It measures oral absorption
Correct Answer: It compares toxic and effective doses
Rationale: The therapeutic index provides an indication of a medication’s safety margin by
comparing doses associated with toxicity and desired effects. A narrow therapeutic index
means relatively small changes in concentration can produce toxicity or treatment failure.
Such medications generally require particularly careful dosing and monitoring.
7. Which physiologic change commonly affects medication handling in older adults?
A) Increased renal clearance
B) Increased total body water
C) Reduced renal function
D) Increased hepatic blood flow
Correct Answer: Reduced renal function
Rationale: Aging is commonly associated with reduced renal function, which can decrease
clearance of renally eliminated medications. Older adults may also experience changes in
hepatic metabolism, body composition, and protein binding. These alterations can increase
drug exposure and adverse effects, making individualized dosing and monitoring especially
important.
8. A medication requiring CYP450 metabolism would be most affected by which situation?
A) Increased dietary fiber alone
B) A clinically significant enzyme inhibitor
C) Increased skeletal muscle mass
D) A medication with identical pharmacologic effects
Correct Answer: A clinically significant enzyme inhibitor
Rationale: CYP450 inhibitors can decrease metabolism of susceptible medications, potentially
increasing their plasma concentrations and toxicity. Conversely, CYP450 inducers may
, accelerate metabolism and reduce drug exposure. The clinical effect depends on the specific
enzyme, substrate, inhibitor or inducer, and therapeutic window of the medication involved.
9. Which finding most strongly suggests a pharmacodynamic drug interaction?
A) One drug changes another drug’s renal clearance
B) One drug alters gastrointestinal absorption
C) Two drugs produce additive physiologic effects
D) One drug increases hepatic metabolism of another
Correct Answer: Two drugs produce additive physiologic effects
Rationale: Pharmacodynamic interactions occur when drugs influence the same physiologic
pathway or response without necessarily changing drug concentrations. Additive sedation
from two central nervous system depressants is an example. Pharmacokinetic interactions
instead alter absorption, distribution, metabolism, or excretion and therefore change drug
exposure.
10. When evaluating medication safety during pregnancy, which period generally
represents the greatest concern for major structural fetal abnormalities?
A) First trimester
B) Second trimester
C) Third trimester
D) Postpartum period
Correct Answer: First trimester
Rationale: Organogenesis occurs primarily during the first trimester, making the developing
embryo particularly vulnerable to teratogenic effects. Drug exposure during later pregnancy
can still cause clinically important fetal or neonatal effects, including altered growth or
toxicity. Therefore, medication decisions require risk-benefit assessment throughout
pregnancy.
11. Which resource specifically provides guidance regarding potentially inappropriate
medications in many older adults?
A) Glasgow Coma Scale
B) Beers Criteria
C) Apgar Score
D) Wells Criteria
Correct Answer: Beers Criteria
